Three Sets of Newly Updated COVID-19 Guidelines Mostly Agree in Their Recommendations... Where Do These COVID-19 Guidelines Currently Disagree?
This Guideline Knowledge Check reviews three sets of newly updated COVID-19 Guidelines (Coronavirus Treatment Guidelines) from the NIH, WHO, and IDSA, as of December 2020, to identify the key differences between the respective COVID-19 treatment guidelines.
Today’s Guideline Knowledge Check question comes from the desk of Med-Challenger Emergency Medicine Editor-in-Chief, Andrea Eberly, MD, FAAEM.
Subscribe for MoreGet more Guideline Knowledge Checks
Try this COVID-19 guideline question and find out if you’re in step with the the most current Coronavirus treatment guidelines.
The COVID-19 guideline committee of a hospital is discussing the incorporation of the following 3 recently published guidelines into their COVID-19 treatment plan: the September 2020 World Health Organization (WHO) guideline and the December 2020 National Institute of Health (NIH) and the Infectious Diseases of America (IDSA) guidelines.
Which of the following statements correctly states a disagreement across these 3 recently updated COVID-19 guidelines?
The three guidelines agree on the use of dexamethasone in critically ill patients, but disagree on its use in those hospitalized with mild disease without oxygen requirement.
The three guidelines disagree on the use of remdesivir.
Only the NIH guideline recommends for routine use of tocilizumab, bamlanivimab.
The NIH and IDSA guidelines advise against the use of chloroquine, whereas the WHO guideline recommends it as an alternate treatment in resource-poor environments without access to remdesivir.
See the Answer:
About Guideline Knowledge Checks:
With each update of national clinical practice guidelines, some recommendations change and many remain unchanged. Med-Challenger Guideline Knowledge Checks help you know both what is new and what has stayed the same in the most recent guidelines pertinent to each medical specialty.
About the Author:
Andrea Eberly, MD, FAAEM graduated from the David Geffen Medical School of Los Angeles (UCLA) and completed her residency in Emergency Medicine at the University Medical Center, Tucson, Arizona. After working as an attending physician in Tucson, she followed a recruiting call to the island of Guam, where she served in various roles, including as the director of the emergency department, the EMS Medical Director of Guam, and the Director of the 911 Call System. She has maintained her emergency medicine board certification through three cycles of American Board of Emergency Medicine Board Exams (last in 2014), all three with the help of Med-Challenger.
More from Med-ChallengerThe Leader in Online Board Review, CME Courses, and Medical Education
Did you like this?
Get more free medical Q&A and informative CME articles.
Subscribe to the Medical Education Blog
More from Med-Challenger's Medical Education Blog
Overuse Syndrome or Septic Joint? – Clinical Patient Case of the WeekJune 21, 2022
June 2022 CME Updates, News, and Offers from Med-ChallengerJune 17, 2022
How Hard Is the ABIM Internal Medicine Certification Exam?June 14, 2022
Board Review & CME Offers
Med-Challenger provides online medical education, top-rated board review courses, annual MOC and CME credit solutions for physicians, nurses, PAs and students. Take advantage of our current offers.